Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label blood products. Show all posts
Showing posts with label blood products. Show all posts
Thursday, May 24, 2012

Effects of Funding Policy Changes and Health Warnings on the Use of Erythropoiesis-Stimulating Agents [Original Contributions]

›
Effects of Funding Policy Changes and Health Warnings on the Use of Erythropoiesis-Stimulating Agents [Original Contributions] Purpose: ...
Saturday, May 19, 2012

paywalled: Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical Consequences [Original Contributions]

›
Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical Consequences [Original Contributions] : Pur...
Wednesday, May 16, 2012

Healthnewsreviews blog: The marketing of anemia drugs - a story we shouldn't forget (including comments)

›
The marketing of anemia drugs - a story we shouldn't forget  "In an opinion piece on TheScientist.com, Daniel W. Coyne writes , ...

paywalled: Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer Patients: Does the Use of Erythropoiesis-Stimulating Agents Worsen Survival?

›
Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer P... : International Journal of Gynecological Cancer Abstract Objecti...
Friday, May 11, 2012

Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron

›
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron Background: Chronic diseases redu...
Saturday, April 14, 2012

abstract: Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer

›
Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chem...
Monday, February 27, 2012

JCO: Are Hematopoietic Colony-Stimulating Factors Over- or Underused?

›
Are Hematopoietic Colony-Stimulating Factors Over- or Underused? "Since their introduction, there has been debate about the benefits,...
Friday, December 17, 2010

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

›
Saturday, May 29, 2010

Randomized Phase 2 Dose-finding Study of Weekly Administration of Darbepoetin Alfa in Anemic Patients with Lung or Ovarian Cancer Receiving Multicycle Platinum-containing Chemotherapy

›
Thursday, January 14, 2010

ACS :: Possible Risks of Blood Product Transfusions

›
Comment: Before Erythropoiesis-stimulating agents were introduced, blood transfusions were widely used for the improvement of platelet count...